ArticleScientific reports2025

Local consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression.

Wangti Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.